Marc Tjwa1, Lieve Moons, Esther Lutgens. 1. Leibniz AG Vascular Hematology, Center for Molecular Medicine, Institute of Cardiovascular Regeneration, University of Frankfurt, Germany.
Abstract
PURPOSE OF REVIEW: Growth arrest-specific gene 6 (Gas6) belongs to the family of vitamin K-dependent coagulation proteins, but in contrast to its other members, has only a limited role in hemostasis. Instead, Gas6 plays a prominent role in conditions of injury, inflammation and repair. Gas6 amplifies the activation of various cell types including endothelial cells and platelets in different models of thrombosis and inflammation, processes also important in atherosclerosis. RECENT FINDINGS: Recently, we showed that in human and murine atherosclerotic plaques, Gas6 is expressed by endothelial cells, smooth muscle cells and most abundantly by macrophages, and that its expression increases with atherosclerosis severity. Moreover, genetic loss of Gas6 in ApoE mice reduced the influx of inflammatory cells in the plaque and induced plaque fibrosis, hence creating a stable plaque phenotype. Consistent herewith, Gas6 plasma levels are increased in patients with unstable angina pectoris, which is a common consequence of atherosclerotic plaque rupture. SUMMARY: Inhibition of Gas6 would be an attractive therapeutic target for stabilizing atherosclerotic plaques and for the prevention of vascular thrombotic occlusion after plaque rupture. Here we will critically review the existing literature on the potential roles of Gas6 and its receptors in the different stages of atherosclerosis.
PURPOSE OF REVIEW: Growth arrest-specific gene 6 (Gas6) belongs to the family of vitamin K-dependent coagulation proteins, but in contrast to its other members, has only a limited role in hemostasis. Instead, Gas6 plays a prominent role in conditions of injury, inflammation and repair. Gas6 amplifies the activation of various cell types including endothelial cells and platelets in different models of thrombosis and inflammation, processes also important in atherosclerosis. RECENT FINDINGS: Recently, we showed that in human and murineatherosclerotic plaques, Gas6 is expressed by endothelial cells, smooth muscle cells and most abundantly by macrophages, and that its expression increases with atherosclerosis severity. Moreover, genetic loss of Gas6 in ApoEmice reduced the influx of inflammatory cells in the plaque and induced plaque fibrosis, hence creating a stable plaque phenotype. Consistent herewith, Gas6 plasma levels are increased in patients with unstable angina pectoris, which is a common consequence of atherosclerotic plaque rupture. SUMMARY: Inhibition of Gas6 would be an attractive therapeutic target for stabilizing atherosclerotic plaques and for the prevention of vascular thrombotic occlusion after plaque rupture. Here we will critically review the existing literature on the potential roles of Gas6 and its receptors in the different stages of atherosclerosis.
Authors: Rafael Van den Bergh; Eric Florence; Erika Vlieghe; Tom Boonefaes; Johan Grooten; Erica Houthuys; Huyen Thi Thanh Tran; Youssef Gali; Patrick De Baetselier; Guido Vanham; Geert Raes Journal: Retrovirology Date: 2010-06-14 Impact factor: 4.602
Authors: Takehiko Shibata; Ugur Burcin Ismailoglu; Nicolai A Kittan; Ana Paula Moreira; Ana Lucia Coelho; Geoffrey L Chupp; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam Journal: Am J Respir Cell Mol Biol Date: 2014-11 Impact factor: 6.914
Authors: V A Tyurin; K Balasubramanian; D Winnica; Y Y Tyurina; A S Vikulina; R R He; A A Kapralov; C H Macphee; V E Kagan Journal: Cell Death Differ Date: 2014-01-24 Impact factor: 15.828
Authors: Erik Biros; Corey S Moran; Jane Maguire; Elizabeth Holliday; Christopher Levi; Jonathan Golledge Journal: Sci Rep Date: 2017-06-28 Impact factor: 4.379
Authors: Ricardo A Verdugo; Tanja Zeller; Maxime Rotival; Philipp S Wild; Thomas Münzel; Karl J Lackner; Henri Weidmann; Ewa Ninio; David-Alexandre Trégouët; François Cambien; Stefan Blankenberg; Laurence Tiret Journal: PLoS One Date: 2013-01-23 Impact factor: 3.240
Authors: Anna Tutusaus; Montserrat Marí; José T Ortiz-Pérez; Gerry A F Nicolaes; Albert Morales; Pablo García de Frutos Journal: Cells Date: 2020-09-28 Impact factor: 6.600